Careers  |  Sign In  |  Register

Latest in Internal Medicine

Pharmacomechanical thrombolysis can be particularly effective in mitigating post-thrombotic syndrome (PTS) in younger patients, as demonstrated by data from the ATTRACT trial.
In this video, recorded at the World Stem Cell Summit 2019, Julie Allickson, PhD, discusses past and current research conducted at the Wake Forest University School of Medicine's Regenerative Medicine Clinical Center. Among the studies mentioned are engineering vaginal and bladder tissues, personalized...
Alcohol use disorder (AUD) is notoriously difficult to treat, but a new therapeutic option may be on the horizon. Ondansetron, a competitive serotonin type 3 receptor antagonist currently used to prevent nausea and vomiting in patients undergoing chemotherapy or radiotherapy, is now being studied in a...